Locally applied drugs [Regulatives / Guidelines]

posted by nobody – 2015-03-02 17:31 (4132 d 20:39 ago) – Posting: # 14532
Views: 6,531

❝ ....Otherwise in case of deep penetration the drug substance would become systemically available, right?


Maybe, but what you are looking for are differences between formulations, e.g. if your new formulation results in higher systemic availability than the originator, which might result in safety issues. Would be hard to determine from the skin data (IIRC there are some Scotch-tape "stripping" models, too, on dermal penetration, resulting in a little more resolution of penetration depth).

A combination with systemic data (ala Maestro) appears mandatory to me, at least in most cases. But maybe I'm even more conservative than Europ. regulators? :-D

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
130 visitors (0 registered, 130 guests [including 15 identified bots]).
Forum time: 15:10 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5